Canada Life’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Canada Life’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-32,882	Closed	-$493K	–	2521
2016 Q2	$493K	Buy	32,882 +29,627	+910%	+$381K	﹤0.01%	1655
2016 Q1	$39K	Hold	3,255	–	–	﹤0.01%	2213
2015 Q4	$52K	Hold	3,255	–	–	﹤0.01%	2130
2015 Q3	$50K	Sell	3,255 -54,654	-94%	-$1.18M	﹤0.01%	2083
2015 Q2	$1.41M	Sell	57,909 -15,500	-21%	-$371K	﹤0.01%	868
2015 Q1	$1.7M	Sell	73,409 -646	-0.9%	-$17.1K	0.01%	828
2014 Q4	$1.86M	Buy	74,055 +1,800	+2%	+$52.8K	0.01%	797
2014 Q3	$2.25M	Buy	72,255 +3,255	+5%	+$88.2K	0.01%	764
2014 Q2	$1.78M	Sell	69,000 -7,900	-10%	-$175K	0.01%	798
2014 Q1	$1.79M	Hold	76,900	–	–	0.01%	796
2013 Q4	$1.96M	Buy	+76,900	New	+$1.74M	0.01%	778

Canada Life's SGNT Position: Q3 2016 in Review

Canada Life sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 32,882 shares — an estimated $493K sold.

Canada Life first reported a position in SGNT in Q4 2013 and held it in 11 quarters. The position peaked at $2.25M in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Canada Life reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Canada Life sold 32,882 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $493K.
Canada Life first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 11 quarters.
Canada Life's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.25M in Q3 2014.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Canada Life's 13F filing for Q3 2016, filed 27 Oct 2016.